Study to Assess Safety and Tolerability of Multiple Doses of EO2002

NCT05636579 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Corneal Edema
Corneal Endothelial Dystrophy
Endothelial Dysfunction
Fuchs Dystrophy
Fuchs' Endothelial Dystrophy
Bullous Keratopathy
Pseudophakic Bullous Keratopathy
Corneal Edema Pseudophakic

Interventions

BIOLOGICAL: EO2002
DRUG: Ripasudil

Sponsor

Asociación para Evitar la Ceguera en México

Collaborators

[object Object]